Lorazepam Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Lorazepam Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on May 3, 2018.

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
65219-368-02
Dosage Form
Injection
Presentation
Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)
Initial Posting
May 3, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.